Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

Amis Amber

28 indexed publications match this author name.

ORCID: Not found in stored metadata
OpenAlex: Not found in stored metadata

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Safety 7 Receptor Pharmacology 7 Brain Imaging 6 Mechanism of Action 5 Depression 5 Emotional Processing 5 Microdosing 5 Observational Study 4 Aging 4 Adverse Events 4 Consciousness 4 Creativity 4

Journals

bioRxiv 3 Psychopharmacology 2 Psychedelic medicine (New Rochelle, N.Y.) 1 Frontiers in Human Neuroscience 1 Antonie van Leeuwenhoek 1 Journal of psychopharmacology (Oxford, England) 1 Biological Psychiatry 1 AJPM Focus 1

Publication history

Assessing The Readiness of Psychiatrists in Louisiana to Incorporate Psilocybin into Clinical Practice-Lessons Learned from a State Underrepresented in Clinical Psychedelic Research.Psychedelic medicine (New Rochelle, N.Y.) · 2026-09-01 Longitudinal neural and psychological changes following psilocybin under compassion imagery primingFrontiers in Human Neuroscience · 2026-07-22 First molecular record of Panaeolus subbalteatus (Psathyrellaceae, Agaricales) from Pakistan.Antonie van Leeuwenhoek · 2026-07-09 Blocking 5-HT2B receptors abolishes psilocybin's efficacy in the rat forced swim test.Journal of psychopharmacology (Oxford, England) · 2026-06-23 356. Psilocybin Therapy is Associated With Decreases in Markers of Mitochondrial Stress and Inflammation in an Open-Label Clinical Trial of Parkinson’s DiseaseBiological Psychiatry · 2026-05-01 Prevalence and Correlates of Past-Year Psilocybin Use in the U.S., 2024, USAAJPM Focus · 2026-05-01 Effects of LSD and Psilocybin on Heart Rate in Patients Receiving Psychedelic Treatment for Depressive and Anxiety Disorders: A Retrospective Observational StudyPsychology International · 2025-12-19 Psilocybin Treatment as an Adjunct to Cognitive Behavioral Therapy for Eating Disorders: Therapeutic Rationale & Considerations for Protocol DevelopmentPreprints.org · 2025-12-19 Real-World Effectiveness and Safety of Psychedelic-Assisted Psychotherapy: Outcomes from a Large-Scale Compassionate Use Cohort in SwitzerlandmedRxiv · 2025-12-01 Psilocybin therapy for mood dysfunction in Parkinson's disease: an open-label pilot trial.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2025-07-01 Psilocybin has a narrow therapeutic window as an antidepressant treatment.Progress in neuro-psychopharmacology & biological psychiatry · 2025-04-02 Psychedelics Align Brain Activity with ContextbioRxiv · 2025-03-11 [The nursing role in psychedelic-assisted psychotherapy].Revue de l'infirmiere · 2024-01-01 Prevalence and associations of challenging, difficult or distressing experiences using classic psychedelics.Journal of affective disorders · 2023-04-01 Classic psychedelic use and current meditation practice.Mindfulness · 2023-04-01 Psilocybin mitigates the cognitive deficits observed in a rat model of Fragile X syndrome.Psychopharmacology · 2023-01-01 Prevalence and associations of classic psychedelic-related seizures in a population-based sample.Drug and alcohol dependence · 2022-10-01 Natural language signatures of psilocybin microdosing.Psychopharmacology · 2022-09-01 Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study.Translational psychiatry · 2022-08-02 Natural language signatures of psilocybin microdosingbioRxiv · 2022-02-22 Classic psychedelics, health behavior, and physical health.Therapeutic advances in psychopharmacology · 2022-01-01 Microevidence for microdosing with psilocybin mushrooms: a double-blind placebo-controlled study of subjective effects, behavior, creativity, perception, cognition, and brain activitybioRxiv · 2021-12-07 Psilocybin: the magic medicine for depression?BJPsych Open · 2021-06-01 Spectral signatures of serotonergic psychedelics and glutamatergic dissociatives.NeuroImage · 2019-10-15 A Randomised, Balanced, Double-blind Two-way Crossover Design Study to Evaluate the Effects of SRC Kinase Inhibitor, Saracatinib, on Brain Activity Associated With Visual Processing in Patients With Parkinson's Disease Psychosis.ClinicalTrials.gov · 2019-08-13 The Experience Elicited by Hallucinogens Presents the Highest Similarity to Dreaming within a Large Database of Psychoactive Substance ReportsFrontiers in Neuroscience · 2018-01-21 Effects of the N343A mutation in TM6 of the human serotonin 5-HT2A ReceptorThe FASEB Journal · 2006-03-01 [Intoxications by hallucinogenic mushrooms].Annales de medecine interne · 2000-10-01

Author directory